验证数据展示
经过测试的应用
Positive FC detected in | Cell stimulation cocktail stimulated mouse splenocytes |
推荐稀释比
应用 | 推荐稀释比 |
---|---|
This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
产品信息
PE-65129 targets CD40L/CD154 in FC applications and shows reactivity with mouse samples.
经测试应用 | FC Application Description |
经测试反应性 | mouse |
免疫原 | N/A 种属同源性预测 |
宿主/亚型 | Armenian Hamster / IgG |
抗体类别 | Monoclonal |
产品类型 | Antibody |
全称 | CD40 ligand |
别名 | CD154, Cd40l, Tnfsf5, Cd40lg, CD40 ligand |
GenBank蛋白编号 | BC119225 |
基因名称 | CD154 |
Gene ID (NCBI) | 21947 |
RRID | AB_2920519 |
偶联类型 | PE Fluorescent Dye |
最大激发/发射波长 | 496 nm, 565 nm / 578 nm |
形式 | Liquid |
纯化方式 | Affinity purification |
UNIPROT ID | P27548 |
储存缓冲液 | PBS with 0.1% sodium azide and 0.5% BSA. |
储存条件 | Store at 2-8°C. Avoid exposure to light. Stable for one year after shipment. |
背景介绍
The CD40 ligand (CD40L, TRAP, CD154), a member of the TNF superfamily of ligands, is expressed as either a 33-kd transmembrane homologue or 18-kd soluble form (sCD154). CD40L is primarily expressed on activated CD4+ T cells and on a small proportion of CD8+ T cells and platelets. It binds to CD40 on antigen-presenting cells (APC), which leads to many effects depending on the target cell type. It has been suggested that CD40/CD40L interactions regulate oxidative stress and affect various signaling pathways in both the immunological and the cardiovascular systems. The CD40/CD40L system is also involved in tumorigenesis. Its expression is tightly regulated, and abnormal levels of CD40L are associated with the pathogenesis of atheromatous plaque destabilization and thrombotic events. Multiple mutations in CD40LG gene have been identified that are associated with hyper-IgM immunodeficiency syndrome type 1.
实验方案
Product Specific Protocols | |
---|---|
FC protocol for PE CD40L/CD154 antibody PE-65129 | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |